🔍
Search Results - kalina+hristova
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Method for Reversible Blood-brain Barrier Opening Using Melittin and Melittin Variants
C15524 Marketing Summary: Method for reversible blood-brain barrier opening using melittin and melittin variants Inventors: Peter Charles Searson,
Kalina Hristova
, Raleigh Linville, Alexander Komin, Piotre Walczak Unmet NeedThe blood-brain barrier (BBB) is responsible for regulating the brain microenvironment by tightly controlling the entry of molecules...
Published: 3/14/2025
|
Inventor(s):
Peter Searson
,
Kalina Hristova
,
Raleigh Linville
,
Alexander Komin
,
Piotr Walczak
Keywords(s):
Category(s):
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
Johns Hopkins University PROTEIN-DB2 Database System
C04853: Johns Hopkins University PROTEIN-DB2 Database SystemNovelty: The current invention is a relational database for proteomic experiments.Value Proposition: Proteomic data collection follows complex workflow, ranging from gel electrophoresis to mass spectrometry to liquid chromatography or a combination thereof. In addition, amplification of low-abundance...
Published: 3/13/2025
|
Inventor(s):
Raimond Winslow
,
Stephen Granite
,
Chunguang Yang
,
Ali Ali
,
Donita Robinson
Keywords(s):
Computer and Network Systems
,
Computer Software
,
Computing; Calculating; Counting
,
Data Processing Systems or Methods, Specifically Adapted fo~
,
Data Processing Systems or Methods, Specifically Adapted for
,
Physics
Category(s):
Technology Classifications > Computers, Electronics & Software > Financial Tech
,
Technology Classifications > Computers, Electronics & Software
,
Technology Classifications > Computers, Electronics & Software > Databases
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025
|
Inventor(s):
Li Lin
Keywords(s):
Biologics
,
Cancers
,
Chemotherapy
,
Disease Indication
,
Nucleic Acid
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum